Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics -  - Libros - Springer Nature Switzerland AG - 9783030098179 - 2 de febrero de 2019
En caso de que portada y título no coincidan, el título será el correcto

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2018 edition

Precio
$ 158,99
sin IVA

Pedido desde almacén remoto

Entrega prevista 26 de jun. - 9 de jul.
Añadir a tu lista de deseos de iMusic

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression.


242 pages, 22 Illustrations, color; XX, 242 p. 22 illus. in color.

Medios de comunicación Libros     Paperback Book   (Libro con tapa blanda y lomo encolado)
Publicado 2 de febrero de 2019
ISBN13 9783030098179
Editores Springer Nature Switzerland AG
Páginas 242
Dimensiones 150 × 220 × 10 mm   ·   406 g
Lengua Alemán  
Editor Elkabets, Moshe
Editor Yarden, Yosef

Mere med samme udgiver